BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+7.47%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+12%)
Cap. Flow
+$146M
Cap. Flow
% of AUM
13.58%
Top 10 Holdings %
Top 10 Hldgs %
83.78%
Holding
22
New
7
Increased
–
Reduced
2
Closed
–
Top Buys
1 |
Annexon
ANNX
|
$98M |
2 |
Nurix Therapeutics
NRIX
|
$44.8M |
3 |
Kymera Therapeutics
KYMR
|
$23.6M |
4 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$14.4M |
5 |
Nautilus Biotechnolgy
NAUT
|
$10.8M |
Top Sells
1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$55.2M |
2 |
Replimune Group
REPL
|
$925K |
Sector Composition
1 | Healthcare | 90.98% |